Joan S. Brugge - Publications

Biology: Medical Sciences, Division of Harvard University, Cambridge, MA, United States 
Cell Biology, General Biophysics, Biomechanics Biophysics

240 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Zoeller JJ, Press MF, Selfors LM, Dering J, Slamon DJ, Hurvitz SA, Brugge JS. Clinical evaluation of BCL-2/XL levels pre- and post- HER2-targeted therapy. Plos One. 16: e0251163. PMID 33951110 DOI: 10.1371/journal.pone.0251163  0.36
2020 Li CM, Shapiro H, Tsiobikas C, Selfors LM, Chen H, Rosenbluth J, Moore K, Gupta KP, Gray GK, Oren Y, Steinbaugh MJ, Guerriero JL, Pinello L, Regev A, Brugge JS. Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing. Cell Reports. 33: 108566. PMID 33378681 DOI: 10.1016/j.celrep.2020.108566  0.36
2020 Naffar-Abu Amara S, Kuiken HJ, Selfors LM, Butler T, Leung ML, Leung CT, Kuhn EP, Kolarova T, Hage C, Ganesh K, Panayiotou R, Foster R, Rueda BR, Aktipis A, Spellman P, ... ... Brugge JS, et al. Transient commensal clonal interactions can drive tumor metastasis. Nature Communications. 11: 5799. PMID 33199705 DOI: 10.1038/s41467-020-19584-1  0.36
2020 Zhao W, Li J, Chen MM, Luo Y, Ju Z, Nesser NK, Johnson-Camacho K, Boniface CT, Lawrence Y, Pande NT, Davies MA, Herlyn M, Muranen T, Zervantonakis IK, von Euw E, ... ... Brugge JS, et al. Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines. Cancer Cell. PMID 33157050 DOI: 10.1016/j.ccell.2020.10.008  0.4
2020 Takahashi N, Cho P, Selfors LM, Kuiken HJ, Kaul R, Fujiwara T, Harris IS, Zhang T, Gygi SP, Brugge JS. 3D Culture Models with CRISPR Screens Reveal Hyperactive NRF2 as a Prerequisite for Spheroid Formation via Regulation of Proliferation and Ferroptosis. Molecular Cell. PMID 33128871 DOI: 10.1016/j.molcel.2020.10.010  0.36
2020 Zervantonakis IK, Poskus MD, Scott AL, Selfors LM, Lin JR, Dillon DA, Pathania S, Sorger PK, Mills GB, Brugge JS. Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways. Proceedings of the National Academy of Sciences of the United States of America. PMID 32601199 DOI: 10.1073/Pnas.2000648117  0.36
2020 Rosenbluth JM, Schackmann RCJ, Gray GK, Selfors LM, Li CM, Boedicker M, Kuiken HJ, Richardson A, Brock J, Garber J, Dillon D, Sachs N, Clevers H, Brugge JS. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nature Communications. 11: 1711. PMID 32249764 DOI: 10.1038/S41467-020-15548-7  0.36
2019 Iavarone C, Zervantonakis IK, Selfors LM, Palakurthi S, Liu JF, Drapkin R, Matulonis UA, Hallberg D, Velculescu VE, Leverson JD, Sampath D, Mills GB, Brugge JS. Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness. Molecular Cancer Therapeutics. PMID 30679390 DOI: 10.1158/1535-7163.MCT-18-0413  0.36
2019 Zoeller JJ, Hurvitz SA, Press MF, Selfors LM, Dering J, Slamon DJ, Brugge JS. Abstract 2978: Clinical evaluation of lapatinib induced BCL-2 adaptive responses Cancer Research. 79: 2978-2978. DOI: 10.1158/1538-7445.Sabcs18-2978  0.36
2019 Cho P, Takahashi N, Selfors LM, Kuiken HJ, Brugge JS. Abstract 884: Interplay between NRF2 and GPX4 is critical for cancer cell survival in 3D spheroids Cancer Research. 79: 884-884. DOI: 10.1158/1538-7445.Am2019-884  0.36
2018 Walker SJ, Selfors LM, Margolis BL, Brugge JS. CRB3 and the FERM protein EPB41L4B regulate proliferation of mammary epithelial cells through the release of amphiregulin. Plos One. 13: e0207470. PMID 30440051 DOI: 10.1371/Journal.Pone.0207470  0.36
2018 Takahashi N, Chen HY, Harris IS, Stover DG, Selfors LM, Bronson RT, Deraedt T, Cichowski K, Welm AL, Mori Y, Mills GB, Brugge JS. Cancer Cells Co-opt the Neuronal Redox-Sensing Channel TRPA1 to Promote Oxidative-Stress Tolerance. Cancer Cell. PMID 29805077 DOI: 10.1016/J.Ccell.2018.05.001  0.36
2018 Hendrick NM, Iwanicki MP, Li CM, Bui DA, Selfors LM, Brugge JS. Abstract 3155: Loss of YAP1 dysregulates RhoA signaling and promotes cell invasion Cancer Research. 78: 3155-3155. DOI: 10.1158/1538-7445.Am2018-3155  0.36
2018 Hamalian S, Güth R, Zervantonakis I, Duell E, Lin J, Shisgal P, Molnar J, Geller C, Agajanian M, Tchou J, Sorger PK, Brugge JS, Kelber JA. Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistance Cancer Research. 78: 2140-2140. DOI: 10.1158/1538-7445.Am2018-2140  0.4
2017 Zoeller JJ, Bronson RT, Selfors LM, Mills GB, Brugge JS. Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo. Npj Breast Cancer. 3: 38. PMID 28948214 DOI: 10.1038/s41523-017-0031-9  0.36
2017 Zervantonakis IK, Iavarone C, Chen HY, Selfors LM, Palakurthi S, Liu JF, Drapkin R, Matulonis U, Leverson JD, Sampath D, Mills GB, Brugge JS. Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. Nature Communications. 8: 365. PMID 28848242 DOI: 10.1038/S41467-017-00263-7  0.36
2017 Zoeller JJ, Bronson RT, Selfors LM, Mills GB, Brugge JS. Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo. Npj Breast Cancer. 3: 18. PMID 28649658 DOI: 10.1038/s41523-017-0020-z  0.36
2017 Sun C, Fang Y, Yin J, Chen J, Ju Z, Zhang D, Chen X, Vellano CP, Jeong KJ, Ng PK, Eterovic AKB, Bhola NH, Lu Y, Westin SN, Grandis JR, ... ... Brugge J, et al. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers. Science Translational Medicine. 9. PMID 28566428 DOI: 10.1126/Scitranslmed.Aal5148  0.4
2017 Iavarone C, Zervantonakis I, Selfors LM, Palakurthi S, Liu JF, Matulonis UA, Drapkin RI, Mills GB, Leverson JD, Sampath D, Brugge JS. Abstract 4033: Combined MEK and BCL-2/XLinhibition as a potential drug combination for the treatment of high-grade serous ovarian cancer Cancer Research. 77: 4033-4033. DOI: 10.1158/1538-7445.Am2017-4033  0.36
2017 Kuiken HJ, Dhakal S, Selfors LM, Crowdis JP, Bhang HC, Stegmeier F, Mills GB, Brugge JS. Abstract 3957: Characterization of functional heterogeneity andin vivodynamics of clonal cell populations derived from the triple-negative breast cancer cell line MDA-MB-468 Cancer Research. 77: 3957-3957. DOI: 10.1158/1538-7445.Am2017-3957  0.36
2016 Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, Zheng M, Adleff V, Papp E, Piao H, Novak M, ... ... Brugge JS, et al. Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for pre-clinical evaluation of novel therapeutics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27573169 DOI: 10.1158/1078-0432.Ccr-16-1237  0.36
2016 Gallegos LL, Ng MR, Sowa ME, Selfors LM, White A, Zervantonakis IK, Singh P, Dhakal S, Harper JW, Brugge JS. A protein interaction map for cell-cell adhesion regulators identifies DUSP23 as a novel phosphatase for β-catenin. Scientific Reports. 6: 27114. PMID 27255161 DOI: 10.1038/Srep27114  0.6
2016 Coloff JL, Brugge JS. How tumor cells cope with the metabolic stress of leaving home. Cell Research. PMID 27216116 DOI: 10.1038/Cr.2016.61  1
2016 Coloff JL, Murphy JP, Braun CR, Harris IS, Shelton LM, Kami K, Gygi SP, Selfors LM, Brugge JS. Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells. Cell Metabolism. PMID 27133130 DOI: 10.1016/J.Cmet.2016.03.016  1
2016 Bui DA, Lee W, White AE, Harper JW, Schackmann RC, Overholtzer M, Selfors LM, Brugge JS. Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. Science Signaling. 9: ra23. PMID 26933062 DOI: 10.1126/Scisignal.Aaa9227  1
2015 Harris IS, Brugge JS. Cancer: The enemy of my enemy is my friend. Nature. 527: 170-1. PMID 26503052 DOI: 10.1038/Nature15644  1
2015 Ince TA, Sousa AD, Jones MA, Harrell JC, Agoston ES, Krohn M, Selfors LM, Liu W, Chen K, Yong M, Buchwald P, Wang B, Hale KS, Cohick E, Sergent P, ... ... Brugge JS, et al. Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nature Communications. 6: 7419. PMID 26080861 DOI: 10.1038/Ncomms8419  1
2015 Ng MR, Besser A, Brugge JS, Danuser G. Correction: Mapping the dynamics of force transduction at cell-cell junctions of epithelial clusters. Elife. 4: e06656. PMID 25642646 DOI: 10.7554/Elife.06656  0.6
2015 Sever R, Brugge JS. Signal transduction in cancer Cold Spring Harbor Perspectives in Medicine. 5. DOI: 10.1101/cshperspect.a006098  1
2014 Ng MR, Besser A, Brugge JS, Danuser G. Mapping the dynamics of force transduction at cell-cell junctions of epithelial clusters. Elife. 3: e03282. PMID 25479385 DOI: 10.7554/Elife.03282  0.6
2014 Gallegos LL, Brugge JS. Live free or die: cell-cell adhesion regulates sensitivity to trail-induced apoptosis. Developmental Cell. 30: 3-4. PMID 25026030 DOI: 10.1016/J.Devcel.2014.06.031  1
2014 Davidowitz RA, Selfors LM, Iwanicki MP, Elias KM, Karst A, Piao H, Ince TA, Drage MG, Dering J, Konecny GE, Matulonis U, Mills GB, Slamon DJ, Drapkin R, Brugge JS. Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. The Journal of Clinical Investigation. 124: 2611-25. PMID 24762435 DOI: 10.1172/Jci69815  1
2014 Godinho SA, Picone R, Burute M, Dagher R, Su Y, Leung CT, Polyak K, Brugge JS, Théry M, Pellman D. Oncogene-like induction of cellular invasion from centrosome amplification. Nature. 510: 167-71. PMID 24739973 DOI: 10.1038/Nature13277  1
2013 Kaanta AS, Virtanen C, Selfors LM, Brugge JS, Neel BG. Evidence for a multipotent mammary progenitor with pregnancy-specific activity. Breast Cancer Research : Bcr. 15: R65. PMID 23947835 DOI: 10.1186/Bcr3459  1
2013 Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J. Chaperone-mediated autophagy degrades mutant p53. Genes & Development. 27: 1718-30. PMID 23913924 DOI: 10.1101/Gad.220897.113  1
2013 Buchwalter G, Hickey MM, Cromer A, Selfors LM, Gunawardane RN, Frishman J, Jeselsohn R, Lim E, Chi D, Fu X, Schiff R, Brown M, Brugge JS. PDEF promotes luminal differentiation and acts as a survival factor for ER-positive breast cancer cells. Cancer Cell. 23: 753-67. PMID 23764000 DOI: 10.1016/J.Ccr.2013.04.026  0.36
2013 Albeck JG, Mills GB, Brugge JS. Frequency-modulated pulses of ERK activity transmit quantitative proliferation signals. Molecular Cell. 49: 249-61. PMID 23219535 DOI: 10.1016/J.Molcel.2012.11.002  1
2013 Amara SN, Selfors LM, Krohn M, Ince TA, Rueda BR, Foster R, Mills GB, Brugge JS. Abstract PR09: Cellular heterogeneity of ovarian carcinoma cells and its impact on tumor behavior Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-Pr09  0.36
2012 Mouneimne G, Hansen SD, Selfors LM, Petrak L, Hickey MM, Gallegos LL, Simpson KJ, Lim J, Gertler FB, Hartwig JH, Mullins RD, Brugge JS. Differential remodeling of actin cytoskeleton architecture by profilin isoforms leads to distinct effects on cell migration and invasion. Cancer Cell. 22: 615-30. PMID 23153535 DOI: 10.1016/J.Ccr.2012.09.027  1
2012 Ng MR, Besser A, Danuser G, Brugge JS. Substrate stiffness regulates cadherin-dependent collective migration through myosin-II contractility. The Journal of Cell Biology. 199: 545-63. PMID 23091067 DOI: 10.1083/Jcb.201207148  1
2012 Brugge JS. Into the deep: Refocusing on 3D. Nature Cell Biology. 14: 332. PMID 22469826 DOI: 10.1038/Ncb2470  1
2012 Worster DT, Schmelzle T, Solimini NL, Lightcap ES, Millard B, Mills GB, Brugge JS, Albeck JG. Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2. Science Signaling. 5: ra19. PMID 22394561 DOI: 10.1126/Scisignal.2001986  1
2012 Davidowitz RA, Iwanicki MP, Brugge JS. In vitro mesothelial clearance assay that models the early steps of ovarian cancer metastasis. Journal of Visualized Experiments : Jove. PMID 22371143 DOI: 10.3791/3888  1
2012 Muranen T, Selfors LM, Worster DT, Iwanicki MP, Song L, Morales FC, Gao S, Mills GB, Brugge JS. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell. 21: 227-39. PMID 22340595 DOI: 10.1016/J.Ccr.2011.12.024  1
2012 Leung CT, Brugge JS. Outgrowth of single oncogene-expressing cells from suppressive epithelial environments. Nature. 482: 410-3. PMID 22318515 DOI: 10.1038/Nature10826  1
2012 Zoeller JJ, Bronson RT, Gilmer TM, Selfors LM, Lu Y, Mills GB, Brugge JS. Abstract P4-08-05: Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo. Cancer Research. 72: 4834-4834. DOI: 10.1158/0008-5472.Sabcs12-P4-08-05  0.4
2011 Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, Danuser G, Ince TA, Ince T, Brugge JS. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discovery. 1: 144-57. PMID 22303516 DOI: 10.1158/2159-8274.Cd-11-0010  1
2011 Grassian AR, Coloff JL, Brugge JS. Extracellular matrix regulation of metabolism and implications for tumorigenesis. Cold Spring Harbor Symposia On Quantitative Biology. 76: 313-24. PMID 22105806 DOI: 10.1101/Sqb.2011.76.010967  1
2011 Wang L, Brugge JS, Janes KA. Intersection of FOXO- and RUNX1-mediated gene expression programs in single breast epithelial cells during morphogenesis and tumor progression. Proceedings of the National Academy of Sciences of the United States of America. 108: E803-12. PMID 21873240 DOI: 10.1073/Pnas.1103423108  1
2011 Grassian AR, Metallo CM, Coloff JL, Stephanopoulos G, Brugge JS. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes & Development. 25: 1716-33. PMID 21852536 DOI: 10.1101/Gad.16771811  1
2011 Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, ... ... Brugge JS, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genetics. 43: 869-74. PMID 21804546 DOI: 10.1038/Ng.890  1
2011 Gallegos L, Ng MR, Brugge JS. The myosin-II-responsive focal adhesion proteome: a tour de force? Nature Cell Biology. 13: 344-6. PMID 21460805 DOI: 10.1038/Ncb2230  1
2011 Kim JH, Cho A, Yin H, Schafer DA, Mouneimne G, Simpson KJ, Nguyen KV, Brugge JS, Montell DJ. Psidin, a conserved protein that regulates protrusion dynamics and cell migration. Genes & Development. 25: 730-41. PMID 21406550 DOI: 10.1101/Gad.2028611  1
2011 Albeck JG, Brugge JS. Uncovering a tumor suppressor for triple-negative breast cancers. Cell. 144: 638-40. PMID 21376226 DOI: 10.1016/J.Cell.2011.02.030  1
2011 Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, Richardson AL, King RW, Cibas ES, Schnitt SJ, Brugge JS, Overholtzer M. A non-genetic route to aneuploidy in human cancers. Nature Cell Biology. 13: 324-30. PMID 21336303 DOI: 10.1038/Ncb2174  1
2011 Grassian AR, Schafer ZT, Brugge JS. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. The Journal of Biological Chemistry. 286: 79-90. PMID 20956544 DOI: 10.1074/Jbc.M110.169821  1
2011 Grassian AR, Metallo CM, Stephanopoulos G, Brugge JS. Abstract 2802: Evaluation of metabolic changes induced by loss of extracellular matrix attachment using 13C Flux analysis Cancer Research. 71: 2802-2802. DOI: 10.1158/1538-7445.Am2011-2802  0.68
2010 Harrison SC, Brugge JS. Mechanistic biology in the next quarter century. Molecular Biology of the Cell. 21: 3799-800. PMID 21079017 DOI: 10.1091/Mbc.E10-05-0441  1
2010 Knowlton ML, Selfors LM, Wrobel CN, Gu TL, Ballif BA, Gygi SP, Polakiewicz R, Brugge JS. Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells. Plos One. 5: e13587. PMID 21049007 DOI: 10.1371/Journal.Pone.0013587  1
2010 Irie HY, Shrestha Y, Selfors LM, Frye F, Iida N, Wang Z, Zou L, Yao J, Lu Y, Epstein CB, Natesan S, Richardson AL, Polyak K, Mills GB, Hahn WC, ... Brugge JS, et al. PTK6 regulates IGF-1-induced anchorage-independent survival. Plos One. 5: e11729. PMID 20668531 DOI: 10.1371/Journal.Pone.0011729  1
2010 Tushir JS, Clancy J, Warren A, Wrobel C, Brugge JS, D'Souza-Schorey C. Unregulated ARF6 activation in epithelial cysts generates hyperactive signaling endosomes and disrupts morphogenesis. Molecular Biology of the Cell. 21: 2355-66. PMID 20462959 DOI: 10.1091/Mbc.E09-09-0824  1
2010 Zhou W, Hur W, McDermott U, Dutt A, Xian W, Ficarro SB, Zhang J, Sharma SV, Brugge J, Meyerson M, Settleman J, Gray NS. A structure-guided approach to creating covalent FGFR inhibitors. Chemistry & Biology. 17: 285-95. PMID 20338520 DOI: 10.1016/J.Chembiol.2010.02.007  1
2010 Janes KA, Wang CC, Holmberg KJ, Cabral K, Brugge JS. Identifying single-cell molecular programs by stochastic profiling. Nature Methods. 7: 311-7. PMID 20228812 DOI: 10.1038/Nmeth.1442  1
2010 Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC, Artavanis-Tsakonas S, Brugge JS. Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 5012-7. PMID 20194747 DOI: 10.1073/Pnas.1000896107  1
2010 Wolfer A, Wittner BS, Irimia D, Flavin RJ, Lupien M, Gunawardane RN, Meyer CA, Lightcap ES, Tamayo P, Mesirov JP, Liu XS, Shioda T, Toner M, Loda M, Brown M, ... Brugge JS, et al. MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proceedings of the National Academy of Sciences of the United States of America. 107: 3698-703. PMID 20133671 DOI: 10.1073/Pnas.0914203107  1
2009 Muller PA, Caswell PT, Doyle B, Iwanicki MP, Tan EH, Karim S, Lukashchuk N, Gillespie DA, Ludwig RL, Gosselin P, Cromer A, Brugge JS, Sansom OJ, Norman JC, Vousden KH. Mutant p53 drives invasion by promoting integrin recycling. Cell. 139: 1327-41. PMID 20064378 DOI: 10.1016/J.Cell.2009.11.026  1
2009 Leung CT, Brugge JS. Tumor self-seeding: bidirectional flow of tumor cells. Cell. 139: 1226-8. PMID 20064369 DOI: 10.1016/J.Cell.2009.12.013  1
2009 Ng MR, Brugge JS. A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell. 16: 455-7. PMID 19962663 DOI: 10.1016/J.Ccr.2009.11.013  1
2009 Iwanicki MP, Brugge JS. Transcriptional regulation of metastatic [Id]entity by KLF17. Genome Biology. 10: 244. PMID 19951400 DOI: 10.1186/Gb-2009-10-11-244  1
2009 Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway. Nature Cell Biology. 11: 1444-50. PMID 19935651 DOI: 10.1038/Ncb1993  1
2009 Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 461: 109-13. PMID 19693011 DOI: 10.1038/Nature08268  1
2009 Mouneimne G, Brugge JS. YB-1 translational control of epithelial-mesenchyme transition. Cancer Cell. 15: 357-9. PMID 19411064 DOI: 10.1016/J.Ccr.2009.04.006  1
2009 Xian W, Pappas L, Pandya D, Selfors LM, Derksen PW, de Bruin M, Gray NS, Jonkers J, Rosen JM, Brugge JS. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival. Cancer Research. 69: 2244-51. PMID 19258500 DOI: 10.1158/0008-5472.Can-08-3398  1
2009 Xian W, Pappas L, Pandya D, Selfors LM, Derksen PW, De Bruin M, Gray NS, Jonkers J, Rosen JM, Brugge JS. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival (Cancer Research (2009) 69 (2244-2251)) Cancer Research. 69: 6366. DOI: 10.1158/0008-5472.Can-69-15-Cor1  1
2008 Simpson KJ, Selfors LM, Bui J, Reynolds A, Leake D, Khvorova A, Brugge JS. Identification of genes that regulate epithelial cell migration using an siRNA screening approach. Nature Cell Biology. 10: 1027-38. PMID 19160483 DOI: 10.1038/Ncb1762  1
2008 Overholtzer M, Brugge JS. The cell biology of cell-in-cell structures. Nature Reviews. Molecular Cell Biology. 9: 796-809. PMID 18784728 DOI: 10.1038/Nrm2504  1
2008 Melani M, Simpson KJ, Brugge JS, Montell D. Regulation of cell adhesion and collective cell migration by hindsight and its human homolog RREB1. Current Biology : Cb. 18: 532-7. PMID 18394891 DOI: 10.1016/J.Cub.2008.03.024  1
2008 Mailleux AA, Overholtzer M, Brugge JS. [Entosis, a cell death process related to cell cannibalism between tumor cells]. MéDecine Sciences : M/S. 24: 246-8. PMID 18334170 DOI: 10.1051/Medsci/2008243246  1
2008 Mailleux AA, Overholtzer M, Brugge JS. Lumen formation during mammary epithelial morphogenesis: insights from in vitro and in vivo models. Cell Cycle (Georgetown, Tex.). 7: 57-62. PMID 18196964 DOI: 10.4161/Cc.7.1.5150  1
2008 Tamimi RM, Brugge JS, Freedman ML, Miron A, Iglehart JD, Colditz GA, Hankinson SE. Circulating colony stimulating factor-1 and breast cancer risk. Cancer Research. 68: 18-21. PMID 18172291 DOI: 10.1158/0008-5472.Can-07-3234  1
2007 Schafer ZT, Brugge JS. IL-6 involvement in epithelial cancers. The Journal of Clinical Investigation. 117: 3660-3. PMID 18060028 DOI: 10.1172/Jci34237  1
2007 Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, Brugge JS. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 131: 966-79. PMID 18045538 DOI: 10.1016/J.Cell.2007.10.040  1
2007 Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, Mooney DJ. Engineering tumors with 3D scaffolds. Nature Methods. 4: 855-60. PMID 17767164 DOI: 10.1038/Nmeth1085  1
2007 Mouneimne G, Brugge JS. Tensins: a new switch in cell migration. Developmental Cell. 13: 317-9. PMID 17765673 DOI: 10.1016/J.Devcel.2007.08.010  1
2007 Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA. Common effector processing mediates cell-specific responses to stimuli. Nature. 448: 604-8. PMID 17637676 DOI: 10.1038/Nature06001  1
2007 Schmelzle T, Mailleux AA, Overholtzer M, Carroll JS, Solimini NL, Lightcap ES, Veiby OP, Brugge JS. Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proceedings of the National Academy of Sciences of the United States of America. 104: 3787-92. PMID 17360431 DOI: 10.1073/Pnas.0700115104  1
2007 Carroll DK, Brugge JS, Attardi LD. p63, cell adhesion and survival Cell Cycle. 6: 255-261. PMID 17297292 DOI: 10.4161/Cc.6.3.3799  1
2007 Mailleux AA, Overholtzer M, Schmelzle T, Bouillet P, Strasser A, Brugge JS. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Developmental Cell. 12: 221-34. PMID 17276340 DOI: 10.1016/J.Devcel.2006.12.003  1
2006 Walker SJ, Brugge JS. SePARating polarity and proliferation in ErbB2 oncogenesis. Nature Cell Biology. 8: 1220-2. PMID 17077856 DOI: 10.1038/Ncb1106-1220  1
2006 Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, Deng CX, Brugge JS, Haber DA. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proceedings of the National Academy of Sciences of the United States of America. 103: 12405-10. PMID 16894141 DOI: 10.1073/Pnas.0605579103  1
2006 Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, Mills AA, Brugge JS, Ellisen LW. p63 regulates an adhesion programme and cell survival in epithelial cells. Nature Cell Biology. 8: 551-61. PMID 16715076 DOI: 10.1038/Ncb1420  1
2006 Wilsbacher JL, Moores SL, Brugge JS. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand. Cell Communication and Signaling : Ccs. 4: 5. PMID 16709244 DOI: 10.1186/1478-811X-4-5  1
2006 Hall AB, Gakidis MA, Glogauer M, Wilsbacher JL, Gao S, Swat W, Brugge JS. Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis. Immunity. 24: 305-16. PMID 16546099 DOI: 10.1016/J.Immuni.2006.02.005  1
2006 Witt AE, Hines LM, Collins NL, Hu Y, Gunawardane RN, Moreira D, Raphael J, Jepson D, Koundinya M, Rolfs A, Taron B, Isakoff SJ, Brugge JS, LaBaer J. Functional proteomics approach to investigate the biological activities of cDNAs implicated in breast cancer. Journal of Proteome Research. 5: 599-610. PMID 16512675 DOI: 10.1021/Pr050395R  1
2005 Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. The Journal of Cell Biology. 171: 1023-34. PMID 16365168 DOI: 10.1083/Jcb.200505087  1
2005 Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Research. 65: 11572-80. PMID 16357167 DOI: 10.1158/0008-5472.Can-05-1196  1
2005 Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, Cantley LC, Brugge JS. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Research. 65: 10992-1000. PMID 16322248 DOI: 10.1158/0008-5472.Can-05-2612  1
2005 Debnath J, Brugge JS. Modelling glandular epithelial cancers in three-dimensional cultures. Nature Reviews. Cancer. 5: 675-88. PMID 16148884 DOI: 10.1038/Nrc1695  1
2005 Yan SR, Joseph RR, Rosen K, Reginato MJ, Jackson A, Allaire N, Brugge JS, Jobin C, Stadnyk AW. Activation of NF-kappaB following detachment delays apoptosis in intestinal epithelial cells. Oncogene. 24: 6482-91. PMID 16007176 DOI: 10.1038/Sj.Onc.1208810  1
2005 Collins NL, Reginato MJ, Paulus JK, Sgroi DC, Labaer J, Brugge JS. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Molecular and Cellular Biology. 25: 5282-91. PMID 15923641 DOI: 10.1128/Mcb.25.12.5282-5291.2005  1
2005 Reginato MJ, Mills KR, Becker EB, Lynch DK, Bonni A, Muthuswamy SK, Brugge JS. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Molecular and Cellular Biology. 25: 4591-601. PMID 15899862 DOI: 10.1128/Mcb.25.11.4591-4601.2005  1
2005 Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, Greer PL, Gao S, Griffith EC, Brugge JS, Greenberg ME. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron. 46: 205-17. PMID 15848800 DOI: 10.1016/J.Neuron.2005.03.019  1
2004 Shaw KR, Wrobel CN, Brugge JS. Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. Journal of Mammary Gland Biology and Neoplasia. 9: 297-310. PMID 15838601 DOI: 10.1007/S10911-004-1402-Z  1
2004 Bill HM, Knudsen B, Moores SL, Muthuswamy SK, Rao VR, Brugge JS, Miranti CK. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Molecular and Cellular Biology. 24: 8586-99. PMID 15367678 DOI: 10.1128/Mcb.24.19.8586-8599.2004  1
2004 Gakidis MA, Cullere X, Olson T, Wilsbacher JL, Zhang B, Moores SL, Ley K, Swat W, Mayadas T, Brugge JS. Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. The Journal of Cell Biology. 166: 273-82. PMID 15249579 DOI: 10.1083/Jcb.200404166  1
2004 Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. The Journal of Cell Biology. 165: 263-73. PMID 15117969 DOI: 10.1083/Jcb.200309102  1
2004 Seton-Rogers SE, Brugge JS. ErbB2 and TGF-beta: a cooperative role in mammary tumor progression? Cell Cycle (Georgetown, Tex.). 3: 597-600. PMID 15107620 DOI: 10.4161/Cc.3.5.886  1
2004 Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, Koh EY, Michelman M, Daley GQ, Brugge JS, Leder P. A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene. 23: 4641-5. PMID 15064711 DOI: 10.1038/Sj.Onc.1207595  1
2004 Mills KR, Reginato M, Debnath J, Queenan B, Brugge JS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is required for induction of autophagy during lumen formation in vitro. Proceedings of the National Academy of Sciences of the United States of America. 101: 3438-43. PMID 14993595 DOI: 10.1073/Pnas.0400443101  1
2004 Seton-Rogers SE, Lu Y, Hines LM, Koundinya M, LaBaer J, Muthuswamy SK, Brugge JS. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 1257-62. PMID 14739340 DOI: 10.1073/Pnas.0308090100  1
2004 Seton-Rogers SE, Brugge JS. ErbB2 and TGF-β: A cooperative role in mammary tumor progression? Cell Cycle. 3: 597-600.  1
2003 Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. The Journal of Experimental Medicine. 198: 1595-608. PMID 14623913 DOI: 10.1084/Jem.20030874  1
2003 Arias-Salgado EG, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proceedings of the National Academy of Sciences of the United States of America. 100: 13298-302. PMID 14593208 DOI: 10.1073/Pnas.2336149100  1
2003 Debnath J, Walker SJ, Brugge JS. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. The Journal of Cell Biology. 163: 315-26. PMID 14568991 DOI: 10.1083/Jcb.200304159  1
2003 Gozani O, Karuman P, Jones DR, Ivanov D, Cha J, Lugovskoy AA, Baird CL, Zhu H, Field SJ, Lessnick SL, Villasenor J, Mehrotra B, Chen J, Rao VR, Brugge JS, et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell. 114: 99-111. PMID 12859901 DOI: 10.1016/S0092-8674(03)00480-X  1
2003 Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, Muthuswamy SK, Brugge JS. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nature Cell Biology. 5: 733-40. PMID 12844146 DOI: 10.1038/Ncb1026  1
2003 Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods (San Diego, Calif.). 30: 256-68. PMID 12798140 DOI: 10.1016/S1046-2023(03)00032-X  1
2002 Gilman AG, Simon MI, Bourne HR, Harris BA, Long R, Ross EM, Stull JT, Taussig R, Bourne HR, Arkin AP, Cobb MH, Cyster JG, Devreotes PN, Ferrell JE, Fruman D, ... ... Brugge JS, et al. Overview of the Alliance for Cellular Signaling. Nature. 420: 703-6. PMID 12478301 DOI: 10.1038/Nature01304  1
2002 Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 111: 29-40. PMID 12372298 DOI: 10.1016/S0092-8674(02)01001-2  1
2002 Chaudhary A, Brugge JS, Cooper JA. Direct phosphorylation of focal adhesion kinase by c-Src: evidence using a modified nucleotide pocket kinase and ATP analog. Biochemical and Biophysical Research Communications. 294: 293-300. PMID 12051709 DOI: 10.1016/S0006-291X(02)00475-8  1
2002 Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nature Cell Biology. 4: E83-90. PMID 11944041 DOI: 10.1038/Ncb0402-E83  1
2002 Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. The Journal of Cell Biology. 157: 265-75. PMID 11940607 DOI: 10.1083/Jcb.200112113  1
2001 Woodside DG, Obergfell A, Leng L, Wilsbacher JL, Miranti CK, Brugge JS, Shattil SJ, Ginsberg MH. Activation of Syk protein tyrosine kinase through interaction with integrin β cytoplasmic domains Current Biology. 11: 1799-1804. PMID 11719224 DOI: 10.1016/S0960-9822(01)00565-6  1
2001 Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini Nature Cell Biology. 3: 785-792. PMID 11533657 DOI: 10.1038/Ncb0901-785  1
2000 Moores SL, Selfors LM, Fredericks J, Breit T, Fujikawa K, Alt FW, Brugge JS, Swat W. Vav family proteins couple to diverse cell surface receptors. Molecular and Cellular Biology. 20: 6364-73. PMID 10938113 DOI: 10.1128/Mcb.20.17.6364-6373.2000  1
2000 Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, Morrison DK, Cobb MH, Marshall MS, Brugge JS. Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Current Biology : Cb. 10: 551-4. PMID 10801448 DOI: 10.1016/S0960-9822(00)00475-9  1
1999 Rao VR, Corradetti MN, Chen J, Peng J, Yuan J, Prestwich GD, Brugge JS. Expression cloning of protein targets for 3-phosphorylated phosphoinositides Journal of Biological Chemistry. 274: 37893-37900. PMID 10608855 DOI: 10.1074/Jbc.274.53.37893  1
1999 Muthuswamy SK, Gilman M, Brugge JS. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Molecular and Cellular Biology. 19: 6845-57. PMID 10490623 DOI: 10.1128/Mcb.19.10.6845  1
1999 Miranti CK, Ohno S, Brugge JS. Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of Shc Journal of Biological Chemistry. 274: 10571-10581. PMID 10187852 DOI: 10.1074/Jbc.274.15.10571  1
1999 Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways: A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells Journal of Biological Chemistry. 274: 7341-7350. PMID 10066798 DOI: 10.1074/Jbc.274.11.7341  1
1999 Brugge JS, McCormick F. Cell regulation intracellular networking Current Opinion in Cell Biology. 11: 173-176. DOI: 10.1016/S0955-0674(99)80022-2  1
1998 Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1 Current Biology. 8: 1289-1299. PMID 9843681 DOI: 10.1016/S0960-9822(07)00559-3  1
1998 Brugge JS. Casting light on focal adhesions Nature Genetics. 19: 309-311. PMID 9697683 DOI: 10.1038/1189  1
1998 Clark EA, King WG, Brugge JS, Symons M, Hynes RO. Integrin-mediated signals regulated by members of the rho family of gtpases Journal of Cell Biology. 142: 573-586. PMID 9679153 DOI: 10.1083/Jcb.142.2.573  1
1998 Brugge JS, Mattaliano M, Miranti C, King W. Integrin regulation of the ERK/MAPK pathway: Complex, interdendent modulation of RAF by RAS, PI 3'-K and PKC Faseb Journal. 12: A1298.  1
1997 Thomas SM, Brugge JS. Cellular functions regulated by SRC family kinases Annual Review of Cell and Developmental Biology. 13: 513-609. PMID 9442882 DOI: 10.1146/Annurev.Cellbio.13.1.513  1
1997 Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ. Regulation of the pp72(syk) protein tyrosine kinase by platelet integrin α(IIb)β3 Embo Journal. 16: 6414-6425. PMID 9351824 DOI: 10.1093/Emboj/16.21.6414  1
1997 King WG, Mattaliano MD, Chan TO, Tsichlis PN, Brugge JS. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Molecular and Cellular Biology. 17: 4406-18. PMID 9234699 DOI: 10.1128/Mcb.17.8.4406  1
1997 Bolen JB, Brugge JS. Leukocyte protein tyrosine kinases: Potential targets for drug discovery Annual Review of Immunology. 15: 371-404. PMID 9143693 DOI: 10.1146/Annurev.Immunol.15.1.371  1
1997 Zoller KE, MacNeil IA, Brugge JS. Protein Tyrosine Kinases Syk and ZAP-70 Display Distinct Requirements for Src Family Kinases in Immune Response Receptor Signal Transduction Journal of Immunology. 158: 1650-1659. PMID 9029101  1
1997 Brugge JS, Clark EA, Shattil SJ. Protein Tyrosine Phosphorylation in Platelets Advances in Molecular and Cell Biology. 18: 335-352. DOI: 10.1016/S1569-2558(08)60420-8  1
1996 Cichowski K, Brugge JS, Brass LF. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets Journal of Biological Chemistry. 271: 7544-7550. PMID 8631786 DOI: 10.1074/Jbc.271.13.7544  1
1996 Brugge JS, Clark EA, King W, Miranti C, Zhou XM, Shatti SS. Regulation of tyrosine phosphorylation by integrins Faseb Journal. 10.  1
1995 Rusanescu G, Qi H, Thomas SM, Brugge JS, Halegoua S. Calcium influx induces neurite growth through a Src-Ras signaling cassette Neuron. 15: 1415-1425. PMID 8845164 DOI: 10.1016/0896-6273(95)90019-5  1
1995 Clark EA, Brugge JS. Integrins and sign transduction pathways: The road taken Science. 268: 233-239. PMID 7716514 DOI: 10.1126/Science.7716514  1
1995 Weng Z, Rickles RJ, Feng S, Richard S, Shaw AS, Schreiber SL, Brugge JS. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Molecular and Cellular Biology. 15: 5627-34. PMID 7565714 DOI: 10.1128/Mcb.15.10.5627  1
1995 Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature. 375: 577-581. PMID 7540725 DOI: 10.1038/375577A0  1
1995 Shiue L, Zoller MJ, Brugge JS. Syk is activated by phosphotyrosine-containing peptides representing the tyrosine-based activation motifs of the high affinity receptor for IgE Journal of Biological Chemistry. 270: 10498-10502. PMID 7537732 DOI: 10.1074/Jbc.270.18.10498  1
1995 Rivera VM, Brugge JS. Clustering of Syk is sufficient to induce tyrosine phosphorylation and release of allergic mediators from rat basophilic leukemia cells Molecular and Cellular Biology. 15: 1582-1590. PMID 7532280 DOI: 10.1128/Mcb.15.3.1582  1
1995 Shiue L, Green J, Green OM, Karas JL, Morgenstern JP, Ram MK, Taylor MK, Zoller MJ, Zydowsky LD, Bolen JB. Interaction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RI. Molecular and Cellular Biology. 15: 272-81. PMID 7528327  1
1995 Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ. Phage display selection of ligand residues important for Src homology 3 domain binding specificity Proceedings of the National Academy of Sciences of the United States of America. 92: 10909-10913. PMID 7479908 DOI: 10.1073/Pnas.92.24.10909  1
1994 Rickles RJ, Botfield MC, Weng Z, Taylor JA, Green OM, Brugge JS, Zoller MJ. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. The Embo Journal. 13: 5598-604. PMID 7988556 DOI: 10.1002/J.1460-2075.1994.Tb06897.X  1
1994 Clark EA, Shattil SJ, Ginsberg MH, Bolen J, Brugge JS. Regulation of the protein tyrosine kinase pp72syk by platelet agonists and the integrin αIIbβ3 Journal of Biological Chemistry. 269: 28859-28864. PMID 7961845  1
1994 Clark EA, Shattil SJ, Brugge JS. Regulation of protein tyrosine kinases in platelets Trends in Biochemical Sciences. 19: 464-469. PMID 7855888 DOI: 10.1016/0968-0004(94)90131-7  1
1994 Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets Current Opinion in Cell Biology. 6: 695-704. PMID 7530462 DOI: 10.1016/0955-0674(94)90096-5  1
1994 Clark EA, Trikha M, Markland FS, Brugge JS. Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation Journal of Biological Chemistry. 269: 21940-21943. PMID 7520909  1
1994 Weng Z, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Dreyfuss G, Brugge JS. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains. Molecular and Cellular Biology. 14: 4509-21. PMID 7516469 DOI: 10.1128/Mcb.14.7.4509  1
1994 Shattil SJ, Haimovich B, Cunningham M, Lipfert L, Parsons JT, Ginsberg MH, Brugge JS. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors Journal of Biological Chemistry. 269: 14738-14745. PMID 7514181  1
1994 Brugge JS. Protein:protein interactions involved in intracellular signal transduction Chemistry and Biology. 1. DOI: 10.1016/1074-5521(94)90023-X  1
1993 Brugge JS. New intracellular targets for therapeutic drug design Science. 260: 918-919. PMID 8388123 DOI: 10.1126/Science.8388123  1
1993 Haimovich B, Lipfert L, Brugge JS, Shattil SJ. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands Journal of Biological Chemistry. 268: 15868-15877. PMID 8340412  1
1993 Weng Z, Taylor JA, Turner CE, Brugge JS, Seidel-Dugan C. Detection of Src homology 3-binding proteins, including paxillin, in normal and v-Src-transformed Balb/c 3T3 cells Journal of Biological Chemistry. 268: 14956-14963. PMID 8325872  1
1993 Lynch SA, Brugge JS, Fromowitz F, Glantz L, Wang P, Caruso R, Viola MV. Increased expression of the src proto-oncogene in hairy cell leukemia and a subgroup ot B-cell lymphomas Leukemia. 7: 1416-1422. PMID 7690441  1
1993 Thomas JE, Aguzzi A, Soriano P, Wagner EF, Brugge JS. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src Oncogene. 8: 2521-2529. PMID 7689725  1
1993 Huang MM, Lipfert L, Cunningham M, Brugge JS, Ginsberg MH, Shattil SJ. Adhesive ligand binding to integrin αIIbβ3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK Journal of Cell Biology. 122: 473-483. PMID 7686553 DOI: 10.1083/Jcb.122.2.473  1
1993 Clark EA, Brugge JS. Redistribution of activated pp60c-src to integrin-dependent cytoskeletal complexes in thrombin-stimulated platelets Molecular and Cellular Biology. 13: 1863-1871. PMID 7680100 DOI: 10.1128/Mcb.13.3.1863  1
1993 Fox JE, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS. On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP IIb-IIIa, pp60c-src, pp62c-yes, and the p21ras GTPase-activating protein with the membrane skeleton. The Journal of Biological Chemistry. 268: 25973-84. PMID 7503992  1
1993 Clark EA, Brugge JS. Tyrosine phosphorylation in platelets. Potential roles in intracellular signal transduction Trends in Cardiovascular Medicine. 3: 218-227. DOI: 10.1016/1050-1738(93)90043-6  1
1992 Seidel-Dugan C, Meyer BE, Thomas SM, Brugge JS. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src Molecular and Cellular Biology. 12: 1835-1845. PMID 1549129 DOI: 10.1128/Mcb.12.4.1835  1
1992 Cichowski K, McCormick F, Brugge JS. p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets Journal of Biological Chemistry. 267: 5025-5028. PMID 1544885  1
1992 Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, Schlessinger J, Pawson T. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 360: 689-92. PMID 1465135 DOI: 10.1038/360689A0  1
1992 Lipfert L, Haimovich B, Schaller MD, Cobb BS, Parsons JT, Brugge JS. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets Journal of Cell Biology. 119: 905-912. PMID 1385445 DOI: 10.1083/Jcb.119.4.905  1
1992 Maroney AC, Qureshi SA, Foster DA, Brugge JS. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Oncogene. 7: 1207-14. PMID 1375718  1
1992 Huang MM, Indik Z, Brass LF, Hoxie JA, Schreiber AD, Brugge JS. Activation of FcγRII induces tyrosine phosphorylation of multiple proteins including FcγRII Journal of Biological Chemistry. 267: 5467-5473. PMID 1372004  1
1992 Schmidt JW, Brugge JS, Nelson WJ. pp60src tyrosine kinase modulates P19 embryonal carcinoma cell fate by inhibiting neuronal but not epithelial differentiation Journal of Cell Biology. 116: 1019-1033. PMID 1370835 DOI: 10.1083/Jcb.116.4.1019  1
1992 Thomas SM, DeMarco M, D'Arcangelo G, Halegoua S, Brugge JS. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases Cell. 68: 1031-1040. PMID 1312392 DOI: 10.1016/0092-8674(92)90075-N  1
1992 Yu H, Rosen MK, Shin TB, Seidel-Dugan C, Brugge JS, Schreiber SL. Solution structure of the SH3 domain of Src and identification of its ligand-binding site Science. 258: 1665-1668. PMID 1280858 DOI: 10.1126/Science.1280858  1
1991 Shattil SJ, Brugge JS. Protein tyrosine phosphorylation and the adhesive functions of platelets Current Opinion in Cell Biology. 3: 869-879. PMID 1931088 DOI: 10.1016/0955-0674(91)90062-4  1
1991 Lord KA, Abdollahi A, Thomas SM, DeMarco M, Brugge JS, Hoffman-Liebermann B, Liebermann DA. Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Molecular and Cellular Biology. 11: 4371-9. PMID 1908551 DOI: 10.1128/Mcb.11.9.4371  1
1991 Thomas SM, Hayes M, D'Arcangelo G, Armstrong RC, Meyer BE, Zilberstein A, Brugge JS, Halegoua S. Induction of neurite outgrowth by v-src mimics critical aspects of nerve growth factor-induced differentiation. Molecular and Cellular Biology. 11: 4739-50. PMID 1875950 DOI: 10.1128/Mcb.11.9.4739  1
1991 Thomas JE, Soriano P, Brugge JS. Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase Science. 254: 568-571. PMID 1719633 DOI: 10.1126/Science.1719633  1
1991 Kremer NE, D'Arcangelo G, Thomas SM, DeMarco M, Brugge JS, Halegoua S. Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of Src and Ras actions Journal of Cell Biology. 115: 809-819. PMID 1717492 DOI: 10.1083/Jcb.115.3.809  1
1991 Huang MM, Bolen JB, Barnwell JW, Shattil SJ, Brugge JS. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets Proceedings of the National Academy of Sciences of the United States of America. 88: 7844-7848. PMID 1715582 DOI: 10.1073/Pnas.88.17.7844  1
1991 Dorai T, Levy JB, Kang L, Brugge JS, Wang LH. Analysis of cDNAs of the proto-oncogene c-src: Heterogeneity in 5′ exons and possible mechanism for the genesis of the 3′ end of v-src Molecular and Cellular Biology. 11: 4165-4176. PMID 1712905 DOI: 10.1128/Mcb.11.8.4165  1
1990 Mitchell CA, Jefferson AB, Bejeck BE, Brugge JS, Deuel TF, Majerus PW. Thrombin-stimulated immunoprecipitation of phosphatidylinositol 3-kinase from human platelets. Proceedings of the National Academy of Sciences of the United States of America. 87: 9396-400. PMID 2174561 DOI: 10.1073/Pnas.87.23.9396  1
1990 Filson AJ, Azarnia R, Beyer EC, Loewenstein WR, Brugge JS. Tyrosine phosphorylation of a gap junction protein correlates with inhibition of cell-to-cell communication Cell Growth &Amp; Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 1: 661-668. PMID 1963075  1
1990 Golden A, Brugge JS, Shattil SJ. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins Journal of Cell Biology. 111: 3117-3127. PMID 1702789 DOI: 10.1083/Jcb.111.6.3117  1
1990 Sugrue MM, Brugge JS, Marshak DR, Greengard P, Gustafson EL. Immunocytochemical localization of the neuron-specific form of the c-src gene product, pp60c-src(+), in rat brain Journal of Neuroscience. 10: 2513-2527. PMID 1696980 DOI: 10.1523/Jneurosci.10-08-02513.1990  1
1989 Levy JB, Brugge JS. Biological and biochemical properties of the c-src+ gene product overexpressed in chicken embryo fibroblasts Molecular and Cellular Biology. 9: 3332-3341. PMID 2477684 DOI: 10.1128/Mcb.9.8.3332  1
1989 Nement SP, Fox LG, DeMarco M, Brugge JS. Deletions within the amino-terminal half of the c-src gene product that alter the functional activity of the protein Molecular and Cellular Biology. 9: 1109-1119. PMID 2471059 DOI: 10.1128/Mcb.9.3.1109  1
1989 Golden A, Brugge JS. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets Proceedings of the National Academy of Sciences of the United States of America. 86: 901-905. PMID 2464830 DOI: 10.1073/Pnas.86.3.901  1
1988 Walaas SI, Lustig A, Greengard P, Brugge JS. Widespread distribution of the c-src gene product in nerve cells and axon terminals in the adult rat brain. Brain Research. 427: 215-22. PMID 3042087 DOI: 10.1016/0169-328X(88)90044-7  1
1988 Schuh SM, Brugge JS. Investigation of factors that influence phosphorylation of pp60c-src on tyrosine 527. Molecular and Cellular Biology. 8: 2465-71. PMID 2457151 DOI: 10.1128/Mcb.8.6.2465  1
1987 Brugge JS, Lustig A, Messer A. Changes in the pattern of expression of pp60(c-src) in cerebellar mutants of mice Journal of Neuroscience Research. 18: 532-538. PMID 3125343 DOI: 10.1002/Jnr.490180405  1
1987 Brugge JS, Jarosik G, Andersen J, Queral-Lustig A, Fedor-Chaiken M, Broach JR. Expression of Rous sarcoma virus transforming protein pp60v-src in Saccharomyces cerevisiae cells Molecular and Cellular Biology. 7: 2180-2187. PMID 3037349 DOI: 10.1128/Mcb.7.6.2180  1
1987 Levy JB, Dorai T, Wang LH, Brugge JS. The structurally distinct form of pp60c-src detected in neuronal cells is encoded by a unique c-src mRNA Molecular and Cellular Biology. 7: 4142-4145. PMID 2448604 DOI: 10.1128/Mcb.7.11.4142  1
1987 Brugge J, Cotton P, Lustig A, Yonemoto W, Lipsich L, Coussens P, Barrett JN, Nonner D, Keane RW. Characterization of the altered form of the c-src gene product in neuronal cells. Genes & Development. 1: 287-96. PMID 2445628 DOI: 10.1101/Gad.1.3.287  1
1987 Yonemoto W, Filson AJ, Queral-Lustig AE, Wang JY, Brugge JS. Detection of phosphotyrosine-containing proteins in polyomavirus middle tumor antigen-transformed cells after treatment with a phosphotyrosine phosphatase inhibitor Molecular and Cellular Biology. 7: 905-913. PMID 2434835 DOI: 10.1128/Mcb.7.2.905  1
1986 Brugge JS, Yonemoto W, Lustig A, Golden A. Investigations of the expression of the cellular src gene product Princess Takamatsu Symposia. 17: 241-249. PMID 3138228  1
1986 Lynch SA, Brugge JS, Levine JM. Induction of altered c-src product during neural differentiation of embryonal carcinoma cells Science. 234: 873-876. PMID 3095923 DOI: 10.1126/Science.3095923  1
1986 Brugge JS. The p35 p36 substrates of protein-tyrosine kinases as inhibitors of phospholipase A2 Cell. 46: 149-150. PMID 2941151 DOI: 10.1016/0092-8674(86)90729-4  1
1986 Golden A, Nemeth SP, Brugge JS. Blood platelets express high levels of the pp60(c-src)-specific tyrosine kinase activity Proceedings of the National Academy of Sciences of the United States of America. 83: 852-856. PMID 2419901 DOI: 10.1073/Pnas.83.4.852  1
1986 Brugge JS. Interaction of the Rous sarcoma virus protein pp60src with the cellular proteins pp50 and pp90 Current Topics in Microbiology and Immunology. 123: 1-22. PMID 2419040 DOI: 10.1007/978-3-642-70810-7_1  1
1985 Yonemoto W, Jarvis-Morar M, Brugge JS, Bolen JB, Israel MA. Tyrosine phosphorylation within the amino-terminal domain of pp60(c-src) molecules associated with polyoma virus middle-sized tumor antigen Proceedings of the National Academy of Sciences of the United States of America. 82: 4568-4572. PMID 3927285 DOI: 10.1073/Pnas.82.14.4568  1
1985 Brugge JS, Cotton PC, Queral AE, Barrett JN, Nonner D, Keane RW. Neurones express high levels of a structurally modified, activated form of pp60c-src. Nature. 316: 554-7. PMID 2412121 DOI: 10.1038/316554A0  1
1984 Brugge JS, Darrow D. Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins Journal of Biological Chemistry. 259: 4550-4557. PMID 6323478  1
1984 Keane RW, Lipsich LA, Brugge JS. Differentiation and transformation of neural plate cells Developmental Biology. 103: 38-52. PMID 6201407 DOI: 10.1016/0012-1606(84)90005-8  1
1984 Lipsich L, Brugge JS, Boettiger D. Expression of the Rous sarcoma virus src gene in avian macrophages fails to elicit transformed cell phenotype Molecular and Cellular Biology. 4: 1420-1424. PMID 6095071 DOI: 10.1128/Mcb.4.7.1420  1
1984 Bolen JB, Thiele CJ, Israel MA, Yonemoto W, Lipsich LA, Brugge JS. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation Cell. 38: 767-777. PMID 6091900 DOI: 10.1016/0092-8674(84)90272-1  1
1984 Chinkers M, Brugge JS. Characterization of structural domains of the human epidermal growth factor receptor obtained by partial proteolysis Journal of Biological Chemistry. 259: 11534-11542. PMID 6088549  1
1983 Lipsich LA, Lewis AJ, Brugge JS. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses Journal of Virology. 48: 352-360. PMID 6312092 DOI: 10.1128/Jvi.48.2.352-360.1983  1
1983 Cotton PC, Brugge JS. Neural tissues express high levels of the cellular src gene product pp60(c-src) Molecular and Cellular Biology. 3: 1157-1162. PMID 6192323 DOI: 10.1128/Mcb.3.6.1157  1
1983 Brugge JS, Darrow D, Lipsich LA, Yonemoto W. The association of the transforming protein of Rous sarcoma virus with two cellular phosphoproteins Progress in Clinical and Biological Research. 119: 135-147. PMID 6191339  1
1983 Brugge JS, Chinkers M. Chapter 22. Tyrosine-Specific Protein Kinases Annual Reports in Medicinal Chemistry. 18: 213-224. DOI: 10.1016/S0065-7743(08)60777-0  1
1982 Lanks KW, Kasambalides EJ, Chinkers M, Brugge JS. A major cytoplasmic glucose-regulated protein is associated with the Rous Sarcoma virus pp60(src) protein Journal of Biological Chemistry. 257: 8604-8607. PMID 6807976  1
1982 Brugge JS, Darrow D. Rous sarcoma virus-induced phosphorylation of a 50,000-molecular weight cellular protein Nature. 295: 250-253. PMID 6276761 DOI: 10.1038/295250A0  1
1982 Lipsich LA, Cutt JR, Brugge JS. Association of the transforming proteins of Rous, Fujinami, and Y73 avian sarcoma viruses with the same two cellular proteins Molecular and Cellular Biology. 2: 875-880. PMID 6100915 DOI: 10.1128/Mcb.2.7.875  1
1981 Brugge JS, Erikson E, Erikson RL. The specific interaction of the Rous sarcoma virus transforming protein, pp60src, with two cellular proteins. Cell. 25: 363-72. PMID 6269742 DOI: 10.1016/0092-8674(81)90055-6  1
1980 Erikson RL, Collett MS, Erikson E, Purchio AF, Brugge JS. Transforming gene product of avian sarcoma viruses and its homolog in uninfected cells. Progress in Clinical and Biological Research. 41: 747-56. PMID 6256774  1
1980 Erikson RL, Purchio AF, Erikson E, Collett MS, Brugge JS. Molecular events in cells transformed by Rous Sarcoma virus. The Journal of Cell Biology. 87: 319-25. PMID 6253501 DOI: 10.1083/Jcb.87.2.319  1
1980 Erikson RI, Collett MS, Erikson E, Purchio AF, Brugge JS. Protein phosphorylation mediated by partially purified avian sarcoma virus transforming-gene product. Cold Spring Harbor Symposia On Quantitative Biology. 44: 907-17. PMID 6253222 DOI: 10.1101/Sqb.1980.044.01.098  1
1979 Lau AF, Krzyzek RA, Brugge JS, Collett MS, Erikson RL, Faras AJ. Expression of the src-gene product, pp60(src), in transformed and reverted mammalian cells infected with avian sarcoma virus Symposia On Quantitative Biology. 44: 1057-1064. PMID 6253180 DOI: 10.1101/Sqb.1980.044.01.114  1
1979 Erikson RL, Brugge JS, Erikson E, Collett MS. Studies on the structure and function of the avian sarcoma virus transforming gene product. Haematology and Blood Transfusion. 23: 261-9. PMID 232457 DOI: 10.1007/978-3-642-67057-2_32  1
1979 Lau AF, Krzyzek RA, Brugge JS, Erikson RL, Schollmeyer J, Faras AJ. Morphological revertants of an avian sarcoma virus-transformed mammalian cell line exhibit tumorigenicity and contain pp60(src) Proceedings of the National Academy of Sciences of the United States of America. 76: 3904-3908. PMID 226988 DOI: 10.1073/Pnas.76.8.3904  1
1979 Collett MS, Erikson E, Purchio AF, Brugge JS, Erikson RL. A normal cell protein similar in structure and function to the avian sarcoma virus transforming gene product. Proceedings of the National Academy of Sciences of the United States of America. 76: 3159-63. PMID 226956 DOI: 10.1073/Pnas.76.7.3159  1
1979 Collett MS, Brugge JS, Erikson RL, Lau AF, Krzyzek RA, Faras AJ. The src gene product of transformed and morphologically reverted ASV-infected mammalian cells Nature. 281: 195-198. PMID 225672 DOI: 10.1038/281195A0  1
1979 Brugge JS, Collett MS, Siddiqui A, Marczynska B, Deinhardt F, Erikson RL. Detection of the viral sarcoma gene product in cells infected with various strains of avian sarcoma virus and of a related protein in uninfected chicken cells Journal of Virology. 29: 1196-1203. PMID 221673 DOI: 10.1128/Jvi.29.3.1196-1203.1979  1
1978 Brugge JS, Steinbaugh PJ, Erikson RL. Characterization of the avian sarcoma virus protein p60src Virology. 91: 130-140. PMID 214955 DOI: 10.1016/0042-6822(78)90361-6  1
1978 Brugge J, Erikson E, Collett MS, Erikson RI. Peptide analysis of the transformation-specific antigen from avian sarcoma virus-transformed cells. Journal of Virology. 26: 773-82. PMID 209218 DOI: 10.1128/Jvi.26.3.773-782.1978  1
1978 Purchio AF, Erikson E, Brugge JS, Erikson RL. Identification of a polypeptide encoded by the avian sarcoma virus src gene. Proceedings of the National Academy of Sciences of the United States of America. 75: 1567-71. PMID 206909 DOI: 10.1073/Pnas.75.3.1567  1
1978 Collett MS, Brugge JS, Erikson RL. Characterization of a normal avian cell protein related to the avian sarcoma virus transforming gene product Cell. 15: 1363-1369. PMID 83198 DOI: 10.1016/0092-8674(78)90061-2  1
1978 Brugge JS, Erikson E, Erikson RL. Antibody to virion structural proteins in mammals bearing avian sarcoma virus-induced tumors. Virology. 84: 429-33. PMID 74898 DOI: 10.1016/0042-6822(78)90259-3  1
1977 Brugge JS, Erikson RL. Identification of a transformation-specific antigen induced by an avian sarcoma virus Nature. 269: 346-348. PMID 198667 DOI: 10.1038/269346A0  1
1977 Erikson E, Brugge JS, Erikson RL. Phosphorylated and nonphosphorylated forms of avian sarcoma virus polypeptide p19. Virology. 80: 177-85. PMID 195394 DOI: 10.1016/0042-6822(77)90390-7  1
1977 Vollet JJ, Brugge JS, Noonan CA, Butel JS. The role of SV40 gene A in the alteration of microfilaments in transformed cells Experimental Cell Research. 105: 119-126. PMID 190024 DOI: 10.1016/0014-4827(77)90157-4  1
1977 Brugge JS, Purchio AF, Erikson RL. The distribution of virus-specific RNA in Rous sarcoma virus-induced hamster tumor cells Virology. 83: 27-33. DOI: 10.1016/0042-6822(77)90208-2  1
1977 Brugge JS, Purchio AF, Erikson RL. Virus-specific RNA species present in the cytoplasm of rous sarcoma virus-infected chicken cells Virology. 83: 16-26. DOI: 10.1016/0042-6822(77)90207-0  1
1976 Noonan CA, Brugge JS, Butel JS. Characterization of simian cells transformed by temperature sensitive mutants of simian virus 40 Journal of Virology. 18: 1106-1119. PMID 178917 DOI: 10.1128/Jvi.18.3.1106-1119.1976  1
1975 Brugge JS, Butel JS. Role of simian virus 40 gene A function in maintenance of transformation Journal of Virology. 15: 619-635. PMID 163376 DOI: 10.1128/Jvi.15.3.619-635.1975  1
1974 Butel JS, Brugge JS, Noonan CA. Transformation of primate and rodent cells by temperature sensitive mutants of SV 40 Symposia On Quantitative Biology. 39: 25-36. PMID 169066 DOI: 10.1101/Sqb.1974.039.01.006  1
Show low-probability matches.